Short Interest in Pulmatrix Inc (NASDAQ:PULM) Expands By 6.0%

Pulmatrix Inc (NASDAQ:PULM) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 699,100 shares, a growth of 6.0% from the May 15th total of 659,500 shares. Approximately 9.1% of the company’s shares are short sold. Based on an average daily trading volume, of 1,730,000 shares, the days-to-cover ratio is presently 0.4 days.

Shares of PULM opened at $0.89 on Friday. The company has a 50 day simple moving average of $0.97. Pulmatrix has a 52-week low of $0.72 and a 52-week high of $5.90.

Pulmatrix (NASDAQ:PULM) last released its earnings results on Wednesday, May 15th. The biotechnology company reported ($0.60) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.59) by ($0.01). Research analysts anticipate that Pulmatrix will post -1.9 earnings per share for the current fiscal year.

Several equities analysts have recently issued reports on PULM shares. Zacks Investment Research lowered Zurich Insurance Group from a “hold” rating to a “sell” rating in a research report on Saturday, April 20th. HC Wainwright restated a “buy” rating on shares of Pulmatrix in a research report on Tuesday, April 16th.

Pulmatrix Company Profile

Pulmatrix, Inc, a clinical stage biopharmaceutical company, develops inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology. Its proprietary product pipeline focuses on advancing treatments for serious lung diseases, including Pulmazole, an inhaled anti-fungal for patients with allergic bronchopulmonary aspergillosis; and PUR1800, kinase inhibitor for patients with obstructive lung diseases, such as asthma and chronic obstructive pulmonary disease (COPD).

See Also: What is the Quick Ratio?

Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.